Hydroxycarbamide Tablets Manufacturers India, Suppliers
The Trusted Manufacturer of Hydroxycarbamide (THAROLAX) Tablets in India
Taj Pharmaceuticals Ltd, a globally recognized name in the pharmaceutical industry, stands as one of the leading manufacturers, suppliers, and exporters of Hydroxycarbamide (Hydroxyurea) Tablets in India. Manufactured under the brand name THAROLAX, these tablets are produced at Taj Pharma’s state-of-the-art facility in Vapi, Gujarat, ensuring premium quality, purity, and global compliance.
Hydroxycarbamide Tablets are a crucial medication widely used in the treatment of head and neck cancers, chronic myeloid leukemia (CML), and sickle cell disease. With years of pharmaceutical excellence, Taj Pharma India has established itself as the most reliable partner for healthcare providers, distributors, and international clients across Africa, the Middle East, and Latin America (LATAM).
About Hydroxycarbamide (Hydroxyurea) Tablets
Hydroxycarbamide, also known as Hydroxyurea, is an antineoplastic agent that interferes with DNA synthesis, effectively inhibiting cancer cell growth. It’s an essential medication in oncology and hematology for its dual therapeutic action—inhibiting tumor cell proliferation and enhancing fetal hemoglobin production in patients with sickle cell disease.
Each THAROLAX Hydroxycarbamide Tablet (100mg) manufactured by Taj Pharmaceuticals Ltd meets stringent international quality standards, ensuring optimal bioavailability, safety, and therapeutic efficacy.
Mechanism of Action: How Hydroxycarbamide Works
In cancer therapy, Hydroxyurea inhibits ribonucleotide reductase, a key enzyme responsible for the conversion of ribonucleotides into deoxyribonucleotides—an essential step in DNA synthesis. By blocking this process, Taj Pharma’s Hydroxycarbamide (THAROLAX) effectively halts the growth of rapidly dividing cancer cells, causing cell cycle arrest and preventing tumor progression.
In sickle cell disease, Hydroxyurea stimulates the production of fetal hemoglobin (HbF) within red blood cells. Elevated HbF levels help reduce the sickling of cells, improving blood flow, decreasing painful vaso-occlusive crises, and minimizing disease-related complications.
Therapeutic Uses of Hydroxycarbamide (Hydroxyurea) Tablets
Taj Pharma’s THAROLAX Hydroxycarbamide Tablets are prescribed for various hematologic and oncologic conditions, including:
- Chronic Myeloid Leukemia (CML): Controls the excessive production of abnormal white blood cells.
- Head and Neck Cancers: Reduces tumor size and enhances the effectiveness of radiotherapy.
- Sickle Cell Anemia: Improves red blood cell flexibility and reduces the frequency of crises.
- Polycythemia Vera: Helps manage elevated red blood cell counts.
Global Presence and Export Network
Taj Pharmaceuticals Ltd has an extensive global footprint, supplying Hydroxycarbamide Tablets to over 70 countries. The company is a trusted exporter to regions such as Africa, the Middle East, and Latin America, with a growing presence in Europe and Southeast Asia.
Through adherence to WHO-GMP, ISO 9001:2015, and EU-GMP standards, Taj Pharma ensures that each batch of Hydroxyurea tablets meets the highest quality, safety, and efficacy benchmarks. The company’s export-ready formulations are supported by comprehensive regulatory documentation (CTD, Dossiers, COPP, and stability data).
Why Choose Taj Pharmaceuticals for Hydroxycarbamide (Hydroxyurea) Tablets?
1. Uncompromising Quality Assurance
Taj Pharma adheres to Good Manufacturing Practices (GMP) and stringent in-process quality control to ensure each THAROLAX tablet meets international standards. Each step, from raw material sourcing to final packaging, is monitored for purity, potency, and consistency.
2. Advanced Manufacturing Infrastructure
Located in Vapi, Gujarat, Taj Pharma’s manufacturing facility is equipped with modern machinery, clean room technology, and automated quality testing equipment, ensuring precise formulation and contamination-free production.
3. Regulatory and Compliance Excellence
The company complies with global pharmacopoeial standards (IP/BP/USP) and maintains detailed regulatory dossiers for global submissions, making Taj Pharma a preferred partner for tender supplies and government contracts.
4. PAN India Distribution and PCD Franchise Opportunities
Taj Pharmaceuticals offers PCD Pharma Franchise partnerships across India, empowering distributors and healthcare professionals with marketing support, promotional materials, and exclusive product rights in their regions.
5. Affordable Global Supply Chain
Despite its world-class standards, Taj Pharma remains committed to affordable healthcare, offering competitive pricing without compromising quality—making it a preferred supplier for hospitals, institutions, and tender agencies worldwide.
Important Safety Information
Hydroxycarbamide (Hydroxyurea) can harm an unborn baby, and both men and women should use effective contraception during treatment and for a period after discontinuation (6 months for women and 1 year for men).
Routine blood monitoring is critical during therapy to assess white blood cells, platelets, and hemoglobin levels. Patients should not alter the dosage or discontinue use without consulting their healthcare provider.
Hydration is essential while on treatment with Hydroxyurea—drinking plenty of fluids supports kidney function and helps reduce potential side effects.
Hydroxycarbamide (Hydroxyurea) Tablets: Available Strengths and Packaging
Taj Pharma manufactures Hydroxycarbamide Tablets (THAROLAX) in 100mg dosage strength, available in blister packs and bulk export packaging options. The packaging is designed for stability and extended shelf life, ensuring product integrity during transportation and storage.
Hydroxycarbamide (Hydroxyurea) Tablets – PCD Pharma Franchise Opportunities
Taj Pharmaceuticals invites pharma distributors, wholesalers, and entrepreneurs to partner through PCD Pharma Franchise programs for Hydroxycarbamide Tablets across India and international markets. Partners benefit from:
- Exclusive distribution rights.
- Competitive margins.
- Marketing and promotional support.
- Access to a wide range of oncology and hematology products.
Commitment to Innovation and Global Health
With decades of experience, Taj Pharmaceuticals Ltd continues to innovate in the oncology and hematology therapeutic segments, ensuring access to safe, effective, and affordable medicines for patients worldwide. The company’s dedication to R&D, regulatory excellence, and ethical manufacturing practices makes it a pioneer in generic formulations like Hydroxycarbamide Tablets (THAROLAX).
As a leading manufacturer, supplier, and exporter of Hydroxycarbamide (Hydroxyurea) Tablets in India, Taj Pharmaceuticals Ltd upholds a reputation built on trust, quality, and innovation. From formulation development to global distribution, Taj Pharma ensures every THAROLAX tablet delivers safety, efficacy, and affordability to patients across the world.
Whether you are a distributor, healthcare provider, or procurement agency, partnering with Taj Pharmaceuticals Ltd guarantees superior quality products, robust supply chains, and unmatched customer support.
